- QIVANA DIFFERENCE
- SKINSHIFT Overview
- SKINSHIFT Edge
- SKINSHIFT Products
- SKINSHIFT Treatments
- SKINSHIFT Supplements
- SKINSHIFT FAQ
- SKINSHIFT Video Overview
- Product Blog
Price Not Announced
Promotes a regular and healthy digestive system by replenishing your intestinal flora with proven strains of human-source bacteria.
PROBIOTIC : (30 Trispheres)
Item# : 210000
Retail price : $32.00
Save 20-30% OFF retail by becoming a Preferred Customer.
Health starts in your gut. It’s where harmful invaders are disarmed, energy is extracted from food, and toxins are removed. These important duties are performed by probiotics – the trillions of friendly bacteria that live in your intestines. Your health depends on their health.
Stress, poor nutrition, prescription drugs, alcohol, and caffeine all compromise this colony, and your health. QORE Probiotics give you billions of new, fresh, healthy bacteria, delivered right to your gut. Our world-class delivery system is superior to any other method for keeping the bacteria alive until they reach your intestine where they can thrive and multiply.
- Probiotics are key to maintaining a regular digestive tract that consistently removes waste and toxins.
- Probiotics are your first line of defense and are critical for a normal immune response to harmful invaders.
- Probiotics make vitamins, extract nutrients from food and ensure proper absorption of nutrients.
Take 1-3 Trisphere capsules any time of day or night. For best results use consistently for a minimum of 90 days.
NOTE: Pregnant or lactating women, diabetics, children under age 12, hypoglycemics, and people with known medical conditions should consult with a physician prior to taking supplements.
Studies have uncovered the fact that most probiotics on the market have a very high percentage of dead organisms, making them useless. Fragile probiotics that require refrigeration make it even more difficult to thrive from the factory to your gut. Many companies ignore the fact that probiotics die in stomach acid and offer liquid, capsule, or food-infused probiotics that have a low probability of making it into the gut alive. Qore Probiotic is delivered in the protective Trisphere® capsule, ensuring the probiotics are properly shielded from temperature fluctuations, external environment, and stomach acid. Laboratory results demonstrate Qore is up to twice as effective for keeping probiotics alive and healthy until they’re delivered to their new home in your intestine.
Vegetable (palm) oil, gelatin (fish source), glycerin, lecithin, pectin and caramel coloring.
1. Olson, Scott. “Have Allergies? Fix Your Gut With Probiotics” http://www.jigsawhealth.com/articles/probiotics-and-the-gut.html. Accessed July 14, 2009.
2. “An Introduction to Probiotics.” National Center for Complementary and Alternative Medicine (NCAM). http://nccam.nih.gov/health/probiotics/. Accessed July 14, 2009.
3. Food and Agriculture Organization of the United Nations (FAO). “Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria.” http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf. 2001.
4. Temmerman R, Pot B, Huys G, Swings J. Int J Food Microbiol.2003 Feb 25;81(1):1-10.
5. Carmichael, M. “Gut Flora? Great!” MSNBC.com. http://www.msnbc.msn.com/id/10754238/site/newsweek/from/ET/. Accessed July 14, 2009.
6. Int J Food Microbiol. 2008 Sep 1;126(3):316-20. Epub August 22, 2007.
7. Holmes, Lindsay. “Bacteria are everywhere.” The Wall Street Journal. March 2009.
8. Aguirre, M., & Collins, M.D. “Lactic acid bacteria and human clinical infections. ” J. Appl. Bact. 75:95-107. (1993).
9. Gasser, F. “Safety of lactic acid bacteria and their occurrence in human clinical infections.” Bull. Inst. Pasteur 92:45-67. (1994).
10. Salminen S., von Wright, A., Morelli, L., Marteau, P., Brassart, D., de Vos, W.M., Fonden, R., Saxelin, M., Collins, K.,Mogensen, G., Birkeland, S.-E., & Mattila-Sandholm, T. “Demonstration of safety of probiotics-a review.” Int. J. Food Prot. 44:93-106. (1998).
11. Borriello, S.P., Hammes, W.P., Holzapfel, W., Marteau, P., Schrezenmeir, J., Vaara, M., & Valtonen, V. “Safety of probiotics that contain lactobacilli or bifidobacteria.” Clin. Infect. Dis. 36:775-780. (2003).
12. Salminen, M.K., Tynkkynen,S., Rautelin, H., Saxelin, M., Vaara, M., Ruutu, P., Seppo Sarna, S., Valtonen, V. & Järvinen, A. “Lactobacillus Bacteremia during a Rapid Increase in Probiotic Use of Lactobacillus rhamnosus GG in Finland. ” Clinical Infectious Diseases; 35:1155-60. (2002).
13. Mogensen, G., Salminen, S., O’Brien, J., Ouwehand, A.C., Holzapfel, W., Shortt, C., Fonden, R., Miller, G.D., Donohue, D., Playne, M., Crittenden, R., Salvadori, B., & Zink, R. “Inventory of microorganisms with a documented history of safe use in food.” Bulletin of the International Dairy Federation. 377: 10-19. (2002).
14. List of taxonomic units proposed for QPS status http://www.efsa.europa.eu/EFSA/Scientific_Opinion/sc_op_ej587_qps_en.pdf.
17. Greene, J.D. & Klaenhammer, T.R. “Factors involved in adherence of lactobacilli to human Caco-2 cells. ” Appl. Environ. Microbiol. 60:4487-4494. (1994).
18. Kleeman, E.G. & Klaenhammer, T.R. “Adherence of Lactobacillus species to human fetal intestinal cells.” J.Dairy Sci. 65:2063-2069. (1982).
21. Gilliland, S. E. & Speck, M. L. “Antagonistic action of Lactobacillus acidophilus toward intestinal and foodborne pathogens in associative cultures.”. J. Food Protect. 40:820-823. (1977).
22. Ouwehand, A.C. & Vesterlund, S. “Antimicrobial components from lactic acid bacteria.” In: S. Salminen, A. von Wright, A. Ouwehand, editors. Lactic acid bacteria.Microbiological and functional aspects. New York: Marcel Dekker, 375-395. (2004).
23. Collado, M.C., Meriluoto, J. & Salminen, S. “Adhesion and aggregation properties of probiotic and pathogen strains.” Eur. Food Res. Technol. 226(5):1065-1073. (2008).
24. Collado, M.C., Meriluoto, J. & Salminen, S. “Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus.” Letters in Applied Microbiology. 45:454-460. (2007).
25. “Oral administration of Bifidobacterium longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice.” Journal of Applied Microbiology, Volume 104 Issue 3, Pages 672 – 680. Published Online: 10 Oct 2007.
26. Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., Dubuquoy, C., Merour, E., Geboes, K., Chamaillard, M., Ouwehand, A., Leyer, G., Carcano, D., Colombel, J-F., Ardid, D. & Desreumaux, P. “Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors.” Nature Medicine, 13(1):35-37. (2007).
27. Sui, J., Leighton, S., Busta, F. & Brady, L. “16s ribosomal DNA analysis of the fecal lactobacilli composition on human subjects consuming a probiotic strain Lactobacillus acidophilus NCFM®.” J. Appl. Microbiol. 93:907-912. (2002).probiotic
28. “Effect of Bifidobacterium longum BB536 on Prevention of Influenza Virus Infections of Elderly.” Abstract of presentation at the 2006 Annual Meeting of Japan Society for Bioscience, Biotechnology, and Agrochemistry (March 25-28, 2006).
29. Park, JH. “Encapsulated Bifidobacterium bifidum potentiates intestinal IgA production.” Cell Immunol. 2002 Sep;219(1):22-7.
30. Human Microbiome Project, nihroadmap.nih.gov/hmp/.
31. Abou-Donia, M.B., El-Masry, E.M., Abdel-Rahman, A.A., McLendon, R.E., Schiffman, S.S. “Splenda Alters Gut Microflora and Increases Intestinal P-Glycoprotein and Cytochrome P-450 in Male Rats.” Journal of Toxicology and Environmental Health, Part A Volume 71, Issue 21, Pages 1415-1429.
32. Engelbrektson, Anna, Korzenik, Joshua R. “Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy.” J Med Microbiol 58 (2009), 663-670; DOI: 10.1099/jmm.0.47615-0 © 2009 Society for General Microbiology.